TokenPost.ai entropy.io purchased the MOONSHOT ticker on Hyperliquid for about $46,068 (574.98 HYPE) on October 19, but no perpetual futures contract under this ticker has started trading. The purchase secures the ticker code but is separate from launching a market, which requires staking 500,000 HYPE and defining contract details. This move is similar to Paragon's recent PAPER ticker acquisition for around $45,000. The MOONSHOT ticker purchase signals potential future market development but lacks details on contract deployment or trading start.
The MOONSHOT ticker purchase by entropy.io on Hyperliquid is noted here alongside Pluang's market snapshot as of Oct 20, 2026 04:42 WIB. Among 50 major cryptocurrencies priced on Pluang, 46 rose and 3 fell today. Key movers include DOT (Polkadot) with a price of Rp20.410 and a 1-day change of +7.63%, ATOM (Cosmos) at Rp31.274 with +7.33%, and EGLD (MultiversX) at Rp64.853 with +6.13%. Typical hold times range from 61 to 121 days, with varying Pluang order activity percentages noted for each asset.
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...
